Cost Savings Ahead Of Schedule Will Improve Profitability By FY '26

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

14 Mar 25

Updated

08 Oct 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

10.9%

7D

2.9%

Loading

1Y

10.9%

7D

2.9%

You can edit this narrative until Oct 9 7:05 PM. Then, changes will post as Updates.

Author's Valuation

UK£1.0527.6% undervalued

AnalystConsensusTarget Fair Value

Shared on 08 Oct 25

Fair value Increased 5.00%

Analysts have raised their price target on Dr. Martens from £0.80 to £1.12 per share, citing expectations that 2025 will mark a turning point for the company and stating that market valuations do not yet reflect its long-term growth potential. Analyst Commentary Market watchers have offered mixed insights following the recent upgrade and price target increase for Dr. Martens.

Shared on 19 Aug 25

Fair value Increased 11%

Despite a notable downgrade in forecast revenue growth and a higher projected future P/E, analysts have nonetheless raised Dr. Martens’ consensus price target from £0.898 to £0.952. What's in the News The Board of Dr. Martens proposed a final dividend of 1.70 pence, maintaining the total dividend for fiscal year 2025 at 2.55 pence, equal to the prior year, pending shareholder approval.

Shared on 01 May 25

Fair value Increased 15%

Shared on 24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 1.27%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Decreased 10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 4.96%

AnalystConsensusTarget Fair Value

UK£1.05

27.6% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

4.78%

Luxury revenue growth rate

0.29%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

10.65%

Calculation

UK£62.70m

Earnings '28

x

21.74x

PE Ratio '28

=

UK£1.36b

Market Cap '28

UK£1.36b

Market Cap '28

/

971.59m

No. shares '28

=

UK£1.40

Share Price '28

UK£1.40 Share Price '28

Discounted to 2025 @ 10.17% p.a.

=

UK£1.05

Fair Value '25